Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling. (Q40216149)
Jump to navigation
Jump to search
scientific article published on October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling. |
scientific article published on October 2006 |
Statements
Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling (English)
Tai W Wong
Francis Y Lee
Chiang Yu
Feng R Luo
Simone Oppenheimer
Hongjian Zhang
Richard A Smykla
Harold Mastalerz
Brian E Fink
Ashvinikumar V Gavai
Gregory D Vite
1 October 2006